These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4654639)

  • 1. Combined effect of xanthinol nicotinate and low molecular weight dextran on survival of dogs subjected to acute hemorrhagic shock.
    Sharma PL
    Indian J Med Res; 1972 Nov; 60(11):1689-96. PubMed ID: 4654639
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of low molecular weight dextran on the survival rate of dogs subjected to acute haemorrhagic shock.
    Sharma PL
    Indian J Med Res; 1970 Nov; 58(11):1613-20. PubMed ID: 5505350
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of xanthinol nicotinate on the survival rate of dogs subjected to acute blood loss.
    Sharma PL
    Q J Exp Physiol Cogn Med Sci; 1969 Oct; 54(4):385-93. PubMed ID: 5201576
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiochemical and metabolic effects of low molecular weight dextran in oligemic shock.
    Schumer W
    J Trauma; 1967 Jan; 7(1):40-7. PubMed ID: 6018131
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of hydroxyethyl starch upon survival of dogs subjected to hemorrhagic shock.
    Ballinger WF; Solanke TF; Thompson WL
    Surg Gynecol Obstet; 1966 Jan; 122(1):33-6. PubMed ID: 5900840
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental evaluation of low molecular weight dextran therapy in irreversible haemorrhagic shock.
    Upadhyaya P; Rao BN; Nayak NC; Sarin R
    Indian J Med Res; 1970 Dec; 58(12):1703-11. PubMed ID: 5509440
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of dextran, ganglioplegic agents and alpha receptor blocking agents on experimental hemorrhagic shock].
    Smolarek F; Korona J; Kobielski J; Stawarz B
    Pol Przegl Chir; 1974 Dec; 46(12):1629-37. PubMed ID: 4155496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Xanthinol-nicotinate (complamine)].
    Cas Lek Cesk; 1968; 107(51):1567-8. PubMed ID: 5700857
    [No Abstract]   [Full Text] [Related]  

  • 9. [The action of xanthinol nicotinate on the peripheral circulation of the aged].
    Chevat H; Steenhouwer B; Hiltenbrand C; Legrand MF; Graux P
    Angeiologie; 1968; 20(2):33-42. PubMed ID: 5682235
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute effect of xanthinol nicotinate on cutaneous and intramuscular temperature in diabetic patients].
    Berezovsky MR; Berstein S; Lopez Morillas AM; Novoa FC; Acuña E; Reitich GE; Gottlieb S
    Prensa Med Argent; 1971 Jul; 58(18):923-31. PubMed ID: 5095397
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective effects of glutathione and xanthinol nicotinate against carbon disulphide poisoning in the mouse.
    Kuljak S; Stern P
    Arh Hig Rada Toksikol; 1971; 22(2):137-42. PubMed ID: 5161207
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of xanthinol nicotinate ("complamin") in Nigerians with cerebral thrombosis.
    Dada TO
    West Afr Med J Niger Pract; 1971 Feb; 20(1):202-5. PubMed ID: 4930360
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of nicotinate of xanthinol prolongatum on the walking distance of patients with arterial insufficiency of the lower extremities].
    Joos F; Basyn M; Rocher A
    Acta Clin Belg; 1972; 27(5):529-47. PubMed ID: 4669777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental studies in animals on the effectiveness of Dextran 75 (Longasteril) in hemorrhagic shock].
    Peter K; Klose R; Graul A; Ungemach J
    Anaesthesist; 1971 May; 20(5):189-92. PubMed ID: 5089586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C
    Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of xanthinol nicotinate on platelet agglutination test].
    Steger W
    Med Welt; 1973 Feb; 24(8):301-2. PubMed ID: 4688216
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of xanthinol-nicotinate on detoxification processes in liver. Experimental studies on the model of hexobarbital-narcosis in rat].
    Brenner G; Trautmann H
    Arzneimittelforschung; 1969 Dec; 19(12):1974-8. PubMed ID: 4245017
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of low molecular weight dextran on circulatory dynamics and oxygen consumption in experimental hemorrhagic shock.
    Smith LL; Staehelin HB; Jolley WB
    Surgery; 1969 Oct; 66(4):782-9. PubMed ID: 5822770
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of hyperlipemia using xantinol-nicotinate].
    Möller-Hardenack B
    Med Monatsschr; 1973 Aug; 27(8):370-2. PubMed ID: 4756297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.